4.06
전일 마감가:
$4.41
열려 있는:
$4.4
하루 거래량:
302.75K
Relative Volume:
1.05
시가총액:
$124.95M
수익:
$72.35M
순이익/손실:
$-45.34M
주가수익비율:
-2.5852
EPS:
-1.5705
순현금흐름:
$-32.43M
1주 성능:
-19.76%
1개월 성능:
-1.46%
6개월 성능:
+19.41%
1년 성능:
-31.65%
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
RCEL
Avita Medical Inc
|
4.06 | 124.95M | 72.35M | -45.34M | -32.43M | -1.5705 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-05 | 개시 | Northland Capital | Outperform |
| 2025-11-20 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2025-08-08 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Avita Medical (RCEL) Upgraded to Buy: Here's Why - Yahoo Finance
Avita Medical Options and Restricted Stock Units Lapse Across Multiple Security Classes - Kalkine
Avita Medical Downgraded to Hold From Speculative Buy by Morgans - Moomoo
Avita Medical Reports Expiry of Over 140,000 Unquoted Securities Across Multiple Series - Kalkine Media
Avita Medical Stock Price Forecast. Should You Buy RCEL? - StockInvest.us
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Raises Target Price to $12 - Moomoo
Price to sales forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – ASX:AVH - TradingView
AVITA Medical, Inc.(NasdaqCM:RCEL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Dynamic Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000E Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Index - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical - The National Law Review
AVITA Medical Inc (RCEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to book forward of AVITA Medical Inc – LS:A2P733 - TradingView
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Price to sales forward of Avita Medical, Inc. – NASDAQ:RCEL - TradingView
BTIG Maintains Avita Medical(RCEL.US) With Hold Rating - Moomoo
AVITA Medical Inc (RCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVITA Medical (RCEL) Showcases RECELL GO Clinical Data at UK Con - GuruFocus
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting - Investing News Network
AVITA Medical’s burn treatment used in 17 U.K. patients - Stock Titan
AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AVITA Medical Inc (RCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AVITA Medical Inc (RCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AVITA Medical Inc (RCEL) Institutional Confidence - TradingKey
AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RCEL to Host Virtual Meeting on June 23 - GuruFocus
AVITA Medical (RCEL) CFO receives 2,000-share equity grant in Form 4 - Stock Titan
Insider Buying: Joseph Woody Acquires Shares of AVITA Medical In - GuruFocus
Avita Medical director Woody Fralin buys $20,800 in common stock - Investing.com
Avita Medical director Woody Fralin buys $20,800 in common stock By Investing.com - Investing.com India
AVITA Medical (RCEL) director adds 5,200 shares in open-market buy - Stock Titan
Avita Medical director Woody Fralin buys $41,900 in stock By Investing.com - Investing.com India
Avita Medical director Woody Fralin buys $41,900 in stock - Investing.com
Insider Buying: Joseph Woody Acquires 10,000 Shares of AVITA Med - GuruFocus
Director Woody Fralin buys 10,000 AVITA Medical (RCEL) shares - Stock Titan
AVITA Medical, Inc. Issues Warrant Certificate to Perceptive Credit Holdings V, LP – Details, Terms, and Signatures - Minichart
AVITA Medical Issues Warrant to Perceptive Tied to $60 Million Credit Facility - TradingView
[8-K] AVITA Medical, Inc. Reports Material Event - Stock Titan
AVITA Medical (RCEL) registers 650,000 shares tied to Perceptive $3.40 warrant - Stock Titan
AVITA Medical (RCEL) director makes 10,000-share open-market stock purchase - Stock Titan
AVITA Medical Stock Is Moving: Shareholder Votes Put Cash, Warrants and Wound-Care Growth in Focus - Bez Kabli
AVITA Medical (RCEL) director receives RSU and stock option awards - Stock Titan
AVITA Medical (NASDAQ: RCEL) grants RSUs and stock options to director - Stock Titan
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):